VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q59591009 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010846.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q59591009‏
024 ‎‡a 0000-0002-3445-0013‏ ‎‡2 orcid‏
024 ‎‡a 56377537900‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q59591009‏
100 0 ‎‡a Michael C Schmid‏ ‎‡c researcher ORCID ID = 0000-0002-3445-0013‏ ‎‡9 en‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a Michael C Schmid‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's A bipartite signal mediates the transfer of type IV secretion substrates of Bartonella henselae into human cells‏
670 ‎‡a Author's A translocated bacterial protein protects vascular endothelial cells from apoptosis‏
670 ‎‡a Author's Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer.‏
670 ‎‡a Author's Blockade of MIF-CD74 Signalling on Macrophages and Dendritic Cells Restores the Antitumour Immune Response Against Metastatic Melanoma.‏
670 ‎‡a Author's Caspase-8 isoform 6 promotes death effector filament formation independent of microtubules.‏
670 ‎‡a Author's Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors‏
670 ‎‡a Author's Circulating Endothelial Progenitor Cells‏
670 ‎‡a Author's Circulating Endothelial Progenitor Cells (CEPC)‏
670 ‎‡a Author's Combined blockade of integrin-α4β1 plus cytokines SDF-1α or IL-1β potently inhibits tumor inflammation and growth‏
670 ‎‡a Author's FF-ATP Synthase Inhibitory Factor 1 in the Normal Pancreas and in Pancreatic Ductal Adenocarcinoma: Effects on Bioenergetics, Invasion and Proliferation‏
670 ‎‡a Author's Impact of tumour associated macrophages in pancreatic cancer.‏
670 ‎‡a Author's Insulin-like growth factor binding protein-3 is overexpressed in endothelial cells of mouse breast tumor vessels.‏
670 ‎‡a Author's Integrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasis.‏
670 ‎‡a Author's Macrophage-Derived Granulin Drives Resistance to Immune Checkpoint Inhibition in Metastatic Pancreatic Cancer‏
670 ‎‡a Author's Macrophage-Mediated Subversion of Anti-Tumour Immunity‏
670 ‎‡a Author's Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma Progression‏
670 ‎‡a Author's Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis.‏
670 ‎‡a Author's Macrophages as Key Drivers of Cancer Progression and Metastasis.‏
670 ‎‡a Author's MST1R kinase accelerates pancreatic cancer progression via effects on both epithelial cells and macrophages‏
670 ‎‡a Author's Myeloid cell trafficking and tumor angiogenesis‏
670 ‎‡a Author's Myeloid cells in the tumor microenvironment: modulation of tumor angiogenesis and tumor inflammation.‏
670 ‎‡a Author's PI3-kinase γ promotes Rap1a-mediated activation of myeloid cell integrin α4β1, leading to tumor inflammation and growth‏
670 ‎‡a Author's PI3Kα activates integrin α4β1 to establish a metastatic niche in lymph nodes.‏
670 ‎‡a Author's PI3Kγ is a molecular switch that controls immune suppression‏
670 ‎‡a Author's Receptor tyrosine kinases and TLR/IL1Rs unexpectedly activate myeloid cell PI3kγ, a single convergent point promoting tumor inflammation and progression.‏
670 ‎‡a Author's The death effector domains of caspase-8 induce terminal differentiation‏
670 ‎‡a Author's The VirB type IV secretion system of Bartonella henselae mediates invasion, proinflammatory activation and antiapoptotic protection of endothelial cells‏
670 ‎‡a Author's UHRF1 regulation of the Keap1-Nrf2 pathway in pancreatic cancer contributes to oncogenesis‏
909 ‎‡a (scopus) 56377537900‏ ‎‡9 1‏
909 ‎‡a (orcid) 0000000234450013‏ ‎‡9 1‏
919 ‎‡a circulatingendothelialprogenitorcellscepc‏ ‎‡A Circulating Endothelial Progenitor Cells (CEPC)‏ ‎‡9 1‏
919 ‎‡a circulatingendothelialprogenitorcells‏ ‎‡A Circulating Endothelial Progenitor Cells‏ ‎‡9 1‏
919 ‎‡a chemoresistanceinpancreaticcancerisdrivenbystromaderivedinsulinlikegrowthfactors‏ ‎‡A Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors‏ ‎‡9 1‏
919 ‎‡a caspase8isoform6promotesdeatheffectorfilamentformationindependentofmicrotubules‏ ‎‡A Caspase-8 isoform 6 promotes death effector filament formation independent of microtubules.‏ ‎‡9 1‏
919 ‎‡a blockadeofmifcd74signallingonmacrophagesanddendriticcellsrestorestheantitumourimmuneresponseagainstmetastaticmelanoma‏ ‎‡A Blockade of MIF-CD74 Signalling on Macrophages and Dendritic Cells Restores the Antitumour Immune Response Against Metastatic Melanoma.‏ ‎‡9 1‏
919 ‎‡a blockadeofinsulinlikegrowthfactorsincreasesefficacyofpaclitaxelinmetastaticbreastcancer‏ ‎‡A Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer.‏ ‎‡9 1‏
919 ‎‡a translocatedbacterialproteinprotectsvascularendothelialcellsfromapoptosis‏ ‎‡A A translocated bacterial protein protects vascular endothelial cells from apoptosis‏ ‎‡9 1‏
919 ‎‡a bipartitesignalmediatesthetransferoftype4secretionsubstratesofbartonellahenselaeintohumancells‏ ‎‡A A bipartite signal mediates the transfer of type IV secretion substrates of Bartonella henselae into human cells‏ ‎‡9 1‏
919 ‎‡a combinedblockadeofintegrinα4β1pluscytokinessdf1αoril1βpotentlyinhibitstumorinflammationandgrowth‏ ‎‡A Combined blockade of integrin-α4β1 plus cytokines SDF-1α or IL-1β potently inhibits tumor inflammation and growth‏ ‎‡9 1‏
919 ‎‡a ffatpsynthaseinhibitoryfactor1inthenormalpancreasandinpancreaticductaladenocarcinomaeffectsonbioenergeticsinvasionandproliferation‏ ‎‡A FF-ATP Synthase Inhibitory Factor 1 in the Normal Pancreas and in Pancreatic Ductal Adenocarcinoma: Effects on Bioenergetics, Invasion and Proliferation‏ ‎‡9 1‏
919 ‎‡a impactoftumourassociatedmacrophagesinpancreaticcancer‏ ‎‡A Impact of tumour associated macrophages in pancreatic cancer.‏ ‎‡9 1‏
919 ‎‡a insulinlikegrowthfactorbindingprotein3isoverexpressedinendothelialcellsofmousebreasttumorvessels‏ ‎‡A Insulin-like growth factor binding protein-3 is overexpressed in endothelial cells of mouse breast tumor vessels.‏ ‎‡9 1‏
919 ‎‡a integrinalpha4beta1signalingisrequiredforlymphangiogenesisandtumormetastasis‏ ‎‡A Integrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasis.‏ ‎‡9 1‏
919 ‎‡a macrophagederivedgranulindrivesresistancetoimmunecheckpointinhibitioninmetastaticpancreaticcancer‏ ‎‡A Macrophage-Derived Granulin Drives Resistance to Immune Checkpoint Inhibition in Metastatic Pancreatic Cancer‏ ‎‡9 1‏
919 ‎‡a macrophagemediatedsubversionofantitumourimmunity‏ ‎‡A Macrophage-Mediated Subversion of Anti-Tumour Immunity‏ ‎‡9 1‏
919 ‎‡a macrophagepi3kγdrivespancreaticductaladenocarcinomaprogression‏ ‎‡A Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma Progression‏ ‎‡9 1‏
919 ‎‡a macrophagesecretedgranulinsupportspancreaticcancermetastasisbyinducingliverfibrosis‏ ‎‡A Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis.‏ ‎‡9 1‏
919 ‎‡a macrophagesaskeydriversofcancerprogressionandmetastasis‏ ‎‡A Macrophages as Key Drivers of Cancer Progression and Metastasis.‏ ‎‡9 1‏
919 ‎‡a mst1rkinaseacceleratespancreaticcancerprogressionviaeffectsonbothepithelialcellsandmacrophages‏ ‎‡A MST1R kinase accelerates pancreatic cancer progression via effects on both epithelial cells and macrophages‏ ‎‡9 1‏
919 ‎‡a myeloidcelltraffickingandtumorangiogenesis‏ ‎‡A Myeloid cell trafficking and tumor angiogenesis‏ ‎‡9 1‏
919 ‎‡a myeloidcellsinthetumormicroenvironmentmodulationoftumorangiogenesisandtumorinflammation‏ ‎‡A Myeloid cells in the tumor microenvironment: modulation of tumor angiogenesis and tumor inflammation.‏ ‎‡9 1‏
919 ‎‡a pi3kinaseγpromotesrap1amediatedactivationofmyeloidcellintegrinα4β1leadingtotumorinflammationandgrowth‏ ‎‡A PI3-kinase γ promotes Rap1a-mediated activation of myeloid cell integrin α4β1, leading to tumor inflammation and growth‏ ‎‡9 1‏
919 ‎‡a pi3kαactivatesintegrinα4β1toestablishametastaticnicheinlymphnodes‏ ‎‡A PI3Kα activates integrin α4β1 to establish a metastatic niche in lymph nodes.‏ ‎‡9 1‏
919 ‎‡a pi3kγisamolecularswitchthatcontrolsimmunesuppression‏ ‎‡A PI3Kγ is a molecular switch that controls immune suppression‏ ‎‡9 1‏
919 ‎‡a receptortyrosinekinasesandtlril1rsunexpectedlyactivatemyeloidcellpi3kγasingleconvergentpointpromotingtumorinflammationandprogression‏ ‎‡A Receptor tyrosine kinases and TLR/IL1Rs unexpectedly activate myeloid cell PI3kγ, a single convergent point promoting tumor inflammation and progression.‏ ‎‡9 1‏
919 ‎‡a deatheffectordomainsofcaspase8induceterminaldifferentiation‏ ‎‡A The death effector domains of caspase-8 induce terminal differentiation‏ ‎‡9 1‏
919 ‎‡a virbtype4secretionsystemofbartonellahenselaemediatesinvasionproinflammatoryactivationandantiapoptoticprotectionofendothelialcells‏ ‎‡A The VirB type IV secretion system of Bartonella henselae mediates invasion, proinflammatory activation and antiapoptotic protection of endothelial cells‏ ‎‡9 1‏
919 ‎‡a uhrf1regulationofthekeap1nrf2pathwayinpancreaticcancercontributestooncogenesis‏ ‎‡A UHRF1 regulation of the Keap1-Nrf2 pathway in pancreatic cancer contributes to oncogenesis‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 DNB|173755291
996 ‎‡2 LNB|LNC10-000070859
996 ‎‡2 BNF|13775254
996 ‎‡2 DNB|119417972X
996 ‎‡2 ISNI|0000000458787213
996 ‎‡2 SZ|1082325856
996 ‎‡2 DE633|pe30005876
996 ‎‡2 DNB|1153843439
996 ‎‡2 DBC|87097992073998
996 ‎‡2 ISNI|0000000083925789
996 ‎‡2 DNB|1075222605
996 ‎‡2 NTA|068714157
996 ‎‡2 LC|n 86118815
996 ‎‡2 ISNI|0000000019876273
996 ‎‡2 DNB|132444445
996 ‎‡2 ISNI|0000000018937230
996 ‎‡2 DNB|139126996
996 ‎‡2 DNB|141895217
996 ‎‡2 LC|no2019007503
996 ‎‡2 DNB|132987538
996 ‎‡2 LC|no2010204128
996 ‎‡2 NUKAT|n 2020217790
996 ‎‡2 SUDOC|169398382
996 ‎‡2 NII|DA10455798
996 ‎‡2 LC|n 97002938
996 ‎‡2 RERO|A003799750
996 ‎‡2 SUDOC|083942262
996 ‎‡2 NKC|xx0145803
996 ‎‡2 ISNI|0000000382973078
996 ‎‡2 ISNI|000000002202969X
996 ‎‡2 DNB|1045692174
996 ‎‡2 NTA|251838072
996 ‎‡2 RERO|A021508042
996 ‎‡2 RERO|A018110236
996 ‎‡2 RERO|A025504208
996 ‎‡2 DNB|1317786181
996 ‎‡2 DNB|13969269X
996 ‎‡2 LC|nb2010015090
996 ‎‡2 DNB|122361970
996 ‎‡2 NSK|000273872
996 ‎‡2 CAOONL|ncf10436966
996 ‎‡2 J9U|987007434422105171
996 ‎‡2 DNB|120083892
996 ‎‡2 ISNI|0000000069321807
996 ‎‡2 DNB|1062363752
996 ‎‡2 LC|n 2008043024
996 ‎‡2 DNB|1297151968
996 ‎‡2 NUKAT|n 2017063062
996 ‎‡2 BNF|12032029
996 ‎‡2 DNB|1166371832
996 ‎‡2 NUKAT|n 2017176318
996 ‎‡2 ISNI|0000000019374521
996 ‎‡2 DNB|1185101543
996 ‎‡2 DNB|128854987
996 ‎‡2 DNB|1240165943
996 ‎‡2 LC|no 95013729
996 ‎‡2 NKC|jo2016908099
996 ‎‡2 DNB|103767444
996 ‎‡2 SUDOC|248901397
996 ‎‡2 DNB|1327094738
996 ‎‡2 LC|no2011074524
996 ‎‡2 DNB|1122326343
996 ‎‡2 DNB|123594243
996 ‎‡2 SZ|1185430199
996 ‎‡2 RERO|A025366548
996 ‎‡2 DNB|1068377631
996 ‎‡2 NUKAT|n 2015183810
996 ‎‡2 DNB|131750585
996 ‎‡2 NUKAT|n 2012156754
996 ‎‡2 LC|n 85108696
996 ‎‡2 DNB|121854841X
996 ‎‡2 DNB|131380923
996 ‎‡2 CAOONL|ncf11328715
996 ‎‡2 DNB|1185430199
996 ‎‡2 ISNI|0000000389703548
996 ‎‡2 RERO|A009445094
996 ‎‡2 DNB|1049704355
996 ‎‡2 DNB|1177705125
996 ‎‡2 DNB|130251321
996 ‎‡2 BNF|14474062
996 ‎‡2 DNB|119997241X
996 ‎‡2 SUDOC|175073643
996 ‎‡2 ISNI|0000000012831638
996 ‎‡2 DNB|1206897589
996 ‎‡2 DNB|1221741020
996 ‎‡2 RERO|A018110609
996 ‎‡2 NKC|ola2003186182
996 ‎‡2 ISNI|0000000114506270
996 ‎‡2 BIBSYS|9030438
996 ‎‡2 RERO|A028834375
996 ‎‡2 ISNI|0000000443139547
996 ‎‡2 DNB|1163247332
996 ‎‡2 PLWABN|9813204294505606
996 ‎‡2 DNB|1226560512
996 ‎‡2 DE633|pe30092396
996 ‎‡2 DNB|124319157
996 ‎‡2 ISNI|0000000080267514
996 ‎‡2 DNB|1185432213
996 ‎‡2 RERO|A018691896
996 ‎‡2 DNB|124319262
996 ‎‡2 DNB|1340972999
996 ‎‡2 DNB|1164540726
996 ‎‡2 NII|DA01595424
996 ‎‡2 ISNI|0000000083934618
996 ‎‡2 DNB|120928450
996 ‎‡2 NKC|xx0044120
996 ‎‡2 SUDOC|194928454
996 ‎‡2 SUDOC|26680652X
996 ‎‡2 NTA|375807640
996 ‎‡2 LC|n 2020003743
996 ‎‡2 PTBNP|60136
996 ‎‡2 DNB|1140565044
996 ‎‡2 SUDOC|168784408
996 ‎‡2 NUKAT|n 2005141019
996 ‎‡2 DNB|1303873710
996 ‎‡2 SUDOC|155717103
996 ‎‡2 SZ|131380923
996 ‎‡2 DNB|106122080X
996 ‎‡2 DNB|115369708
996 ‎‡2 LC|no2021071874
996 ‎‡2 DNB|1047174235
996 ‎‡2 ISNI|0000000109468513
996 ‎‡2 RERO|A018110333
996 ‎‡2 DNB|1133570836
996 ‎‡2 NII|DA10254515
996 ‎‡2 DE633|pe30030820
996 ‎‡2 DNB|118012428
996 ‎‡2 LC|no2009067884
996 ‎‡2 DNB|1330460804
996 ‎‡2 PLWABN|9810665826305606
996 ‎‡2 NUKAT|n 97005382
996 ‎‡2 LC|n 00007340
996 ‎‡2 DNB|123791383
996 ‎‡2 DNB|142691992
996 ‎‡2 DNB|120500477
996 ‎‡2 SZ|1075222605
996 ‎‡2 ISNI|0000000079927853
996 ‎‡2 SZ|1166371832
996 ‎‡2 RERO|A003588830
996 ‎‡2 BIBSYS|6058702
996 ‎‡2 RERO|A018110534
996 ‎‡2 DNB|1013970330
996 ‎‡2 PLWABN|9813703970205606
996 ‎‡2 BIBSYS|1024966
996 ‎‡2 SUDOC|171324064
996 ‎‡2 BIBSYS|97020090
996 ‎‡2 ISNI|0000000369677899
996 ‎‡2 DNB|112103179X
996 ‎‡2 DNB|1157408680
996 ‎‡2 BIBSYS|13058143
996 ‎‡2 SZ|1185101543
996 ‎‡2 LC|no2011061583
996 ‎‡2 SUDOC|028495977
996 ‎‡2 CAOONL|ncf10024196
996 ‎‡2 ISNI|0000000035729986
996 ‎‡2 DNB|140510826
996 ‎‡2 DNB|1116585243
996 ‎‡2 NTA|238572528
996 ‎‡2 DNB|139145656
996 ‎‡2 DNB|1082325856
996 ‎‡2 NKC|skuk0005069
996 ‎‡2 DNB|17392073X
996 ‎‡2 JPG|500055262
996 ‎‡2 BNF|15606352
996 ‎‡2 ISNI|0000000014656802
996 ‎‡2 DNB|1035709708
996 ‎‡2 ISNI|0000000381619851
996 ‎‡2 ISNI|0000000014931640
996 ‎‡2 DNB|1243950803
996 ‎‡2 ISNI|0000000010633494
996 ‎‡2 NTA|115756469
996 ‎‡2 RERO|A013642956
996 ‎‡2 ISNI|0000000388854061
996 ‎‡2 J9U|987007271421605171
996 ‎‡2 ISNI|000000001502089X
996 ‎‡2 DNB|1012302431
996 ‎‡2 DNB|133689212
996 ‎‡2 BIBSYS|90147454
996 ‎‡2 DNB|139517421
996 ‎‡2 DNB|130582638
996 ‎‡2 LC|no2003039128
996 ‎‡2 DNB|123810051
996 ‎‡2 DNB|132670976
996 ‎‡2 J9U|987007376942605171
996 ‎‡2 DNB|1014319129
996 ‎‡2 RERO|A023853519
996 ‎‡2 RERO|A000008135
996 ‎‡2 DNB|143060317
996 ‎‡2 ISNI|0000000431680213
996 ‎‡2 DNB|117502308
996 ‎‡2 DNB|135917484
996 ‎‡2 DNB|124283772
996 ‎‡2 SZ|1185432213
996 ‎‡2 DNB|141622857
996 ‎‡2 ISNI|0000000496596784
996 ‎‡2 ISNI|000000003097216X
996 ‎‡2 SZ|139126996
996 ‎‡2 LC|n 84035423
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏